2025 ACIP Meetings Summary

Looking across the June, September, and December 2025 ACIP meetings reveals a critical trajectory. Early June discussions tended to focus on individual products or narrow data points. By September, problematic claims increasingly involved clinical trial design, evidence standards, and regulatory processes. By December, multiple statements reflected broad and inaccurate characterizations of the childhood immunization schedule, vaccine safety science, and the legal and ethical frameworks that govern vaccine policy in the United States.

This document consolidates selected examples from ACIP’s 2025 meetings based on their potential relevance to clinical practice, public understanding, or vaccine policy, and was evaluated against primary sources, including peer-reviewed studies, systematic reviews, and broader scientific evidence. Its purpose is to clarify where scientific standards were strained or misapplied, to support transparency and public understanding, and to help anticipate future ACIP meetings, the earliest of which is expected to take place in February 2026.